01:55 AM EDT, 07/30/2026 (MT Newswires) -- Sanofi (SAN.PA) said Thursday its net income for the first half declined, while net sales rose year over year. Net income attributable to equity holders for the six months ended June 30 was 1.96 billion euros, compared with 5.81 billion euros a year ago. Basic EPS moved to 1.63 euros from 4.74 euros. The French pharmaceutical company's net sales were 22.11 billion euros, compared with 19.89 billion euros a year ago. For 2026, the company upgraded its outlook for sales to grow by 10% at constant exchange rates, with business EPS at constant exchange rates increasing slightly faster than sales.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.